Lab Sample to Commercial Batch: Why Gummy Formulas Change During Scale-Up

A successful laboratory gummy proves that a concept can be made under small-scale conditions. It does not prove that the same formula can be mixed, transferred, deposited, dried, coated, tested, and packaged consistently in a commercial plant.

Scale changes the physical environment around the formula. Heating and cooling take longer. Transfer lines add hold time. Powder can settle. Depositor pressure and line speed affect unit weight. Drying rooms expose thousands of units to spatial differences that are absent from a tray of samples.

The objective of gummy scale-up is therefore not to copy the laboratory procedure by multiplying every number. It is to preserve the product's critical quality attributes while translating the process into commercial equipment.

Quick Answer

Treat Scale-Up as a Controlled Development Stage

A credible scale-up plan should connect:

  • A locked product brief and formula revision

  • Raw-material form and variability

  • Commercial mixing and dispersion

  • Time and temperature exposure

  • Slurry viscosity and hold time

  • Depositing accuracy and unit weight

  • Setting, drying, coating, and conditioning

  • Finished-product potency and uniformity

  • Packaging compatibility

  • A documented commercial trial and release decision

Brands should expect some process adjustment. They should not accept unexplained formula drift or a commercial batch that is materially different from the approved sample.

Why the Laboratory Sample Is Different

Small Equipment Hides Commercial Risks

Laboratory batches are usually mixed quickly, moved short distances, and deposited soon after preparation. Operators can intervene manually when viscosity, temperature, or appearance changes.

Commercial production may involve larger vessels, pumps, hoses, filters, manifolds, and multiple depositor heads. The mass of product has greater thermal inertia, and the first units may experience different conditions from the last.

A bench sample may also use hand-selected units. Commercial quality must describe the full lot, including normal variation in weight, shape, drying position, coating, and package fill.

Formula Lock

Define What Is Allowed to Change

Before a scale trial, approve a controlled formula and product specification. Record the active forms, excipient grades, flavors, colors, gelling system, sweetener system, target batch size, target unit weight, serving count, and intended package.

Separate three categories:

  • Fixed attributes that support the label or product promise

  • Process parameters that may be adjusted within an approved range

  • Formula changes that require brand approval and new evaluation

If the commercial team can substitute ingredients or change active load without a formal review, the approved sample no longer provides a reliable reference.

Raw-Material Scale Effects

The Same Ingredient Name May Not Behave the Same

Particle size, bulk density, moisture, viscosity, bloom strength, degree of esterification, buffering capacity, and carrier composition can change processing behavior.

At scale, these differences affect how powders are charged, dispersed, hydrated, and suspended. A fine mineral may thicken the mass differently from a coarse grade. An oil-based vitamin may require an emulsion strategy. A fiber syrup can alter solids, water activity, and drying.

Qualify the commercial material, supplier, specification, and lot. Do not conduct the scale trial with an unapproved substitute and assume equivalence.

Mixing and Dispersion

Similar Mixing Time Does Not Mean Similar Mixing

Mixer geometry, blade position, shear, fill level, and addition sequence determine how energy enters the batch. Simply multiplying laboratory mixing time can under-mix one zone and overwork another.

For suspended actives, the scale-up team should evaluate:

  • Preblend or slurry preparation

  • Powder addition rate

  • Agglomeration and wetting

  • Mixer speed and load

  • Recirculation or sweep mixing

  • Air incorporation

  • Sampling location

  • Settling during hold and transfer

Beginning-middle-end finished samples can help show whether the active remained distributed during depositing.

Time and Temperature

Follow Product Exposure, Not Only Kettle Setpoints

Commercial batches often heat and cool more slowly. Product may remain in a vessel or transfer system while the line is adjusted.

Track the time-temperature history from ingredient addition through the end of depositing. This is particularly important for heat-sensitive vitamins, live microorganisms, volatile flavors, acid-sensitive actives, and hydrocolloid setting.

The relevant question is not whether the kettle reached a target temperature. It is how long the formula and each sensitive component experienced specific conditions.

Viscosity and Hold Time

The Depositor Needs a Stable Processing Window

Gummy mass can change while it waits. Solids concentration, temperature, hydration, acid addition, and gel development affect viscosity.

If viscosity rises too far, filling may become incomplete or unit weights may drift. If the mass is too fluid, suspended powder may settle and the final gel may be weak.

Define an operating window for temperature, time, viscosity or a justified surrogate, agitation, and maximum hold. Record conditions during the trial instead of relying on operator memory.

Depositing and Unit Weight

Dose Control Depends on Each Unit

The formulation can meet its concentration target while individual gummies miss the intended dose because unit weight varies.

Commercial evaluation should include:

  • Target and acceptable unit weight

  • Depositor settings and line speed

  • Head-to-head variation

  • Start-up and shutdown material

  • Beginning-middle-end weight checks

  • Mold fill and tailing

  • Reject criteria

When the serving contains multiple gummies, the label calculation still depends on controlled unit weight and active distribution.

Setting, Drying, and Conditioning

Thousands of Gummies Must Reach the Same State

Airflow, temperature, humidity, tray loading, residence time, and gummy position can create different drying histories.

Evaluate moisture, water activity, texture, surface condition, shape, and weight across representative locations. Averages alone can hide wet zones that later stick or support microbial risk and dry zones that become hard.

Drying is not complete merely because the gummy can be demolded. The finished product must reach a controlled state suitable for coating, packaging, and shelf life.

Coating and Packaging

Downstream Steps Can Change the Product

Oil, wax, sugar, acid, or powder coatings affect appearance, handling, flavor, and sometimes moisture behavior. Packaging adds another microenvironment.

Confirm coating level, transfer damage, count accuracy, seal integrity, headspace needs, desiccant decisions, and barrier properties. Stability samples should use the intended commercial package rather than an unrelated laboratory container.

Commercial Trial Evidence

Define Success Before Running the Batch

A commercial trial protocol should identify the formula, equipment, batch size, critical parameters, sampling plan, tests, acceptance criteria, deviations, and approvers.

Useful evidence includes:

  • Actual process records

  • In-process temperature, time, and weight data

  • Yield and reconciliation

  • Beginning-middle-end samples

  • Finished potency and relevant uniformity data

  • Moisture, water activity, pH, and texture

  • Microbiological and contaminant results as applicable

  • Packaging inspection

  • Retains and stability placement

Success is a documented conclusion, not the visual impression of a few good gummies.

Common Scale-Up Changes

Adjustment Does Not Automatically Mean Failure

A scale trial may require changes to mixing sequence, dispersion method, heat timing, flavor addition, acid timing, depositor settings, drying duration, or coating.

Each change should be linked to an observed risk and reviewed for effects on the label, specification, sensory profile, analytical method, and shelf life.

Uncontrolled additions of water, acid, flavor, or active material during production can solve one immediate problem while creating another. Record and approve adjustments.

Red Flags

  • The commercial formula has no revision control

  • The factory approves scale-up from a hand sample alone

  • Process limits are described only as operator experience

  • No beginning-middle-end samples are collected

  • Unit weight is checked without finished potency

  • Drying is judged only by touch

  • The package used for stability differs from the launch pack

  • Deviations are corrected but not documented

  • The first saleable batch doubles as an undocumented trial

Questions for a Gummy Manufacturer

  1. What changes between your laboratory, pilot, and commercial equipment?

  2. Which attributes are considered critical for this formula?

  3. How do you control suspended actives during hold and transfer?

  4. What is the maximum commercial hold time?

  5. How are depositor-head and run-stage differences evaluated?

  6. Which tests are completed before release?

  7. What constitutes a successful commercial trial?

  8. How are formula or process changes approved?

  9. Will launch-package samples enter stability?

  10. What evidence must exist before repeat production?

How VitaMFG Approaches Gummy Scale-Up

Preserve the Product Intent Through Commercial Production

VitaMFG begins with the intended dose, unit weight, serving count, gelling and sweetener system, sensory target, market, package, and testing requirements.

Scale-up review then connects raw-material behavior, mixing, active dispersion, time-temperature exposure, viscosity, depositing, drying, coating, finished testing, and stability.

Where a laboratory concept conflicts with commercial equipment or a stable product window, the issue is identified before routine production. Facility-level quality controls support the process, while batch-specific records and finished-product evidence support the product decision.

Frequently Asked Questions

Does a successful sample prove manufacturability?

No. It proves laboratory feasibility under the sample conditions. Commercial manufacturability requires a controlled scale trial and representative finished-product evidence.

Must the formula change during scale-up?

Not always. Process parameters often change, and some formulas require controlled adjustment. Any material formula change should be approved and re-evaluated.

Can the first commercial order be the trial?

It can create substantial risk if trial objectives, sampling, acceptance criteria, and disposition are not defined. A planned engineering or validation approach is safer.

Why test beginning, middle, and end samples?

They can reveal settling, viscosity drift, temperature effects, depositor changes, and unit-weight variation across the run.

Final Recommendation

Treat gummy scale-up as a technical transfer, not a multiplication exercise.

Approve the product brief, define critical attributes, record commercial process conditions, sample across the run, test the finished product, and place the launch package on stability.

If your brand has a laboratory sample or an existing formula that must move to commercial production, VitaMFG can review the initial gummy feasibility and scale-up risks before a full manufacturing commitment.

  • FDA: Current Good Manufacturing Practice for Dietary Supplements — https://www.fda.gov/regulatory-information/search-fda-guidance-documents/small-entity-compliance-guide-current-good-manufacturing-practice-manufacturing-packaging-labeling

  • Electronic Code of Federal Regulations: 21 CFR Part 111 — https://www.ecfr.gov/current/title-21/chapter-I/subchapter-B/part-111